prednisolone has been researched along with Granulocytic Leukemia, Chronic in 56 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Massive pleural effusion developed in a 59-year-old male patient with chronic myeloid leukemia, who was being treated with bosutinib." | 8.31 | Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors. ( Aslan, NA; Elver, Ö; Erol, V; Güler, N; Hıncal, HO, 2023) |
| " daily) caused a decrease in fibrinogen levels in nine patients treated for lymphoid blast crisis LBC) of chronic myeloid leukemia (CML)." | 7.68 | Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. ( Bettelheim, P; Korninger, C; Lechner, K; Pabinger-Fasching, I; Speiser, W; Stain, M; Sunder-Plassmann, G, 1991) |
| " Cyclosporine, methotrexate and prednisone were used for graft-versus-host disease (GVHD) prophylaxis." | 5.07 | Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide. ( Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M, 1994) |
| "Massive pleural effusion developed in a 59-year-old male patient with chronic myeloid leukemia, who was being treated with bosutinib." | 4.31 | Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors. ( Aslan, NA; Elver, Ö; Erol, V; Güler, N; Hıncal, HO, 2023) |
| " The co-administration of prednisolone was thus tried, and she has been able to continue imatinib mesylate administration without any liver dysfunction and finally was able to obtain a complete cytogenetic response." | 3.73 | Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management. ( Ikuta, K; Inamura, J; Jimbo, J; Kohgo, Y; Miyokawa, N; Sato, K; Shindo, M; Tokusashi, Y; Torimoto, Y, 2005) |
| " This occurred during an exacerbation of graft-versus-host disease (GVHD) and both problems remitted after therapy with cyclosporine and prednisolone." | 3.68 | Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. ( Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ, 1992) |
| " daily) caused a decrease in fibrinogen levels in nine patients treated for lymphoid blast crisis LBC) of chronic myeloid leukemia (CML)." | 3.68 | Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. ( Bettelheim, P; Korninger, C; Lechner, K; Pabinger-Fasching, I; Speiser, W; Stain, M; Sunder-Plassmann, G, 1991) |
| "The drug is used for the treatment of chronic myeloid leukemia, malignant gastrointestinal stromal tumors, and some other conditions." | 2.44 | Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review. ( Pubalan, M; Wahiduzzaman, M, 2008) |
| " Imatinib mesylate, a recently introduced specific tyrosine kinase inhibitor of BCR-ABL, in combination with chemotherapy, resulted in more than 90% hematologic CR in adult Ph-positive ALL, including molecular CR in more than 50% of patients." | 2.43 | Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. ( Ohno, R, 2006) |
| "Sweet's syndrome (SS), acute febrile neutrophilic dermatosis, has been linked to hematologic malignancies and presents with characteristic edematous dermal plaques." | 2.40 | Sweet's syndrome without granulocytosis. ( al-Mondhiry, H; Ballard, J; Ehmann, WC; Helm, KF; Probert, C, 1998) |
| "We describe a patient with chronic myelogenous leukemia (CML) and a patient with hairy cell leukemia being effectively treated with alpha-interferon who developed a seropositive chronic polyarthritis formally fulfilling the ACR criteria for rheumatoid arthritis." | 2.40 | [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature]. ( Einsele, H; Kanz, L; Kötter, I; Mohren, M; Müller, CA, 1999) |
| "Ph1-positive chronic myelocytic leukemia (CML) developing in a treated case of acute promyelocytic leukemia (APL) is reported." | 2.38 | [Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia]. ( Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y, 1989) |
| "Immune thrombocytopenia (ITP) and chronic myeloid leukemia (CML) are rarely observed concurrently." | 1.91 | Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia. ( Itoh, Y; Nakamura, Y; Wakimoto, N, 2023) |
| "We discuss a case of nilotinib-induced interstitial lung disease presenting with nonspecific interstitial pneumonia on the unilateral lung." | 1.72 | A case report of nilotinib-induced irreversible interstitial lung disease. ( Cho, JY; Kim, D; Kwon, J; Lee, OJ; Shin, YM, 2022) |
| "A 61-year-old patient with chronic myeloid leukemia was treated with IM at 400 mg daily dose." | 1.62 | Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia. ( Charfi, M; Elloumi, M; Kallel, F; Kassar, O; Ksouda, K; Maaloul, I, 2021) |
| "Dasatinib was discontinued and the patient received intravenous immunoglobulin (IVIg), resulting in resolution of the symptoms." | 1.48 | Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia. ( Akagawa, N; Higashihara, M; Iizuka, T; Ishida, T; Miyata, T; Miyazaki, K; Suzuki, T; Tominaga, N, 2018) |
| "The abnormal cell types in chronic myeloid leukemia (CML) and monoclonal gammopathy of uncertain (MGUS) are quite different, being myeloid and plasma cells, respectively." | 1.48 | Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report. ( Lu, S; Ouyang, W; Wang, Z; Zhao, X, 2018) |
| "We present a case of nilotinib-induced interstitial lung disease (ILD)." | 1.39 | Nilotinib-induced interstitial lung disease. ( Go, SI; Kang, JH; Kang, MH; Kim, HG; Lee, GW; Lee, JH; Lee, WS, 2013) |
| "Treatment with prednisolone (1 mg/kg/d) began on approximately day 300." | 1.31 | Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. ( Kuwana, M; Mashima, Y; Mori, T; Nakajima, T; Ogawa, Y; Oguchi, Y; Okamoto, S; Tsubota, K; Watanabe, R; Yamada, M, 2001) |
| "A 37-year-old Japanese man with chronic myeloid leukemia (CML) developed myasthenia gravis 29 months after bone marrow transplantation (BMT) from an HLA one locus-mismatched brother." | 1.29 | Myasthenia gravis after allogeneic bone marrow transplantation. ( Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K, 1994) |
| "A case of nonoliguric acute renal failure complicated with tumor lysis syndrome is described." | 1.28 | [Nonoliguric acute renal failure complicated with tumor lysis syndrome in chronic myelocytic leukemia in lymphoid crisis]. ( Ishikawa, Y; Kobayashi, R; Matsumoto, T; Naito, H; Shikano, T; Tonooka, T, 1991) |
| "They were ALL(6), ANLL(8), CML(1) and NHL(1)." | 1.27 | [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia]. ( Hatae, Y; Hatayama, Y; Nakadate, H; Takeda, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (16.07) | 18.7374 |
| 1990's | 17 (30.36) | 18.2507 |
| 2000's | 16 (28.57) | 29.6817 |
| 2010's | 10 (17.86) | 24.3611 |
| 2020's | 4 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JY | 1 |
| Lee, OJ | 1 |
| Kwon, J | 1 |
| Kim, D | 1 |
| Shin, YM | 1 |
| Aslan, NA | 1 |
| Hıncal, HO | 1 |
| Elver, Ö | 1 |
| Erol, V | 1 |
| Güler, N | 1 |
| Nakamura, Y | 3 |
| Itoh, Y | 1 |
| Wakimoto, N | 1 |
| Kallel, F | 1 |
| Kassar, O | 1 |
| Maaloul, I | 1 |
| Charfi, M | 1 |
| Ksouda, K | 1 |
| Elloumi, M | 1 |
| Ishida, T | 1 |
| Akagawa, N | 1 |
| Miyata, T | 1 |
| Tominaga, N | 1 |
| Iizuka, T | 1 |
| Higashihara, M | 1 |
| Suzuki, T | 1 |
| Miyazaki, K | 1 |
| Kopp, CR | 1 |
| Jandial, A | 1 |
| Mishra, K | 1 |
| Sandal, R | 1 |
| Malhotra, P | 1 |
| Ouyang, W | 1 |
| Zhao, X | 1 |
| Lu, S | 1 |
| Wang, Z | 1 |
| Boo, YL | 1 |
| Liam, CCK | 1 |
| Toh, SG | 1 |
| Lim, SM | 1 |
| Santopietro, M | 1 |
| Miano, M | 1 |
| Palumbo, G | 1 |
| Zhang, K | 1 |
| Cardarelli, L | 1 |
| Chiaretti, S | 1 |
| Peragine, N | 1 |
| Nanni, M | 1 |
| Diverio, D | 1 |
| Mancini, F | 1 |
| Testi, AM | 1 |
| Moleti, ML | 1 |
| Foà, R | 1 |
| Giona, F | 1 |
| Go, SI | 1 |
| Lee, WS | 1 |
| Lee, GW | 1 |
| Kang, JH | 1 |
| Kang, MH | 1 |
| Lee, JH | 1 |
| Kim, HG | 1 |
| Lee, HY | 1 |
| Lee, KH | 1 |
| Hyun, MS | 1 |
| Kim, MK | 1 |
| Koh, SA | 1 |
| Cho, HS | 1 |
| Eishei Oskuei, A | 1 |
| Makhdoomi, K | 1 |
| Abkhiz, S | 1 |
| Vossoghian, S | 1 |
| Farrokhpour, M | 1 |
| Tokita, K | 1 |
| Nagasawa, F | 1 |
| Takahashi, W | 1 |
| Sasaki, K | 1 |
| Ichikawa, M | 1 |
| Mitani, K | 1 |
| Wahiduzzaman, M | 1 |
| Pubalan, M | 1 |
| Nagasaki, Y | 1 |
| Miyamoto, T | 1 |
| Henzan, H | 1 |
| Nagafuji, K | 1 |
| Harada, M | 2 |
| Akashi, K | 1 |
| Matsunaga, T | 1 |
| Cunningham, S | 1 |
| Muneer, S | 1 |
| Ranganathan, A | 1 |
| Shrader, M | 1 |
| Ohno, R | 1 |
| Suehiro, T | 1 |
| Masutani, K | 1 |
| Yokoyama, M | 1 |
| Tokumoto, M | 1 |
| Tsuruya, K | 1 |
| Fukuda, K | 1 |
| Kanai, H | 1 |
| Katafuchi, R | 1 |
| Nagatoshi, Y | 1 |
| Hirakata, H | 1 |
| Au, WY | 1 |
| Ma, SK | 1 |
| Wan, TS | 1 |
| Wang, EP | 1 |
| Lau, TC | 1 |
| Kwong, YL | 1 |
| INAI, S | 1 |
| FUJIKAWA, K | 1 |
| MASAOKA, T | 1 |
| TAKAHASHI, H | 1 |
| NAGAKI, K | 1 |
| SPASSKII, OV | 1 |
| MURTHY, BG | 1 |
| Murakami, T | 1 |
| Shibazaki, K | 1 |
| Kurokawa, K | 1 |
| Ichikawa, Y | 1 |
| Ohsawa, Y | 1 |
| Sunada, Y | 1 |
| Isshiki, I | 1 |
| Yamaguchi, K | 1 |
| Okamoto, S | 2 |
| Arimura, K | 1 |
| Arima, N | 1 |
| Ohtsubo, H | 1 |
| Matsushita, K | 1 |
| Kukita, T | 1 |
| Ayukawa, T | 1 |
| Kuroki, T | 1 |
| Tei, C | 1 |
| Ikuta, K | 1 |
| Torimoto, Y | 1 |
| Jimbo, J | 1 |
| Inamura, J | 1 |
| Shindo, M | 1 |
| Sato, K | 1 |
| Tokusashi, Y | 1 |
| Miyokawa, N | 1 |
| Kohgo, Y | 1 |
| Al Sobhi, E | 1 |
| Zahrani, Z | 1 |
| Zevallos, E | 1 |
| Zuraiki, A | 1 |
| Govind Babu, K | 1 |
| Attili, VS | 1 |
| Bapsy, PP | 1 |
| Anupama, G | 1 |
| Shimoda, K | 1 |
| Gondo, H | 1 |
| Sano, T | 1 |
| Nakamura, M | 1 |
| Otsuka, T | 1 |
| Okamura, S | 1 |
| Niho, Y | 1 |
| Galimberti, M | 1 |
| Polchi, P | 1 |
| Lucarelli, G | 1 |
| Angelucci, E | 1 |
| Baronciani, D | 1 |
| Giardini, C | 1 |
| Gaziev, D | 1 |
| Erer, B | 1 |
| Ripalti, M | 1 |
| Rapa, S | 1 |
| Mughal, T | 1 |
| Morleda, J | 1 |
| Goldman, J | 1 |
| Kitabayashi, A | 1 |
| Miura, I | 1 |
| Ito, T | 1 |
| Takahashi, M | 2 |
| Chubachi, A | 1 |
| Niitsu, H | 1 |
| Mamiya, S | 1 |
| Miura, AB | 1 |
| Kuyama, J | 1 |
| Take, H | 1 |
| Mahé, B | 1 |
| Gaillard, F | 1 |
| Labadie, F | 1 |
| Papin, S | 1 |
| Letortorec, S | 1 |
| Moreau, P | 1 |
| Harousseau, JL | 1 |
| Milpied, N | 1 |
| Fleischman, EW | 1 |
| Volkova, MA | 1 |
| Frenkel, MA | 1 |
| Konstantinova, LN | 1 |
| Kulagina, OE | 1 |
| Baranov, AE | 1 |
| Gordeeva, AA | 1 |
| Gerber, M | 1 |
| Gmeinhart, B | 1 |
| Volc-Platzer, B | 1 |
| Kalhs, P | 1 |
| Greinix, H | 1 |
| Knobler, R | 1 |
| Probert, C | 1 |
| Ehmann, WC | 1 |
| al-Mondhiry, H | 1 |
| Ballard, J | 1 |
| Helm, KF | 1 |
| Brandenburg, U | 1 |
| Gottlieb, D | 1 |
| Bradstock, K | 1 |
| Kötter, I | 1 |
| Müller, CA | 1 |
| Einsele, H | 1 |
| Mohren, M | 1 |
| Kanz, L | 1 |
| Ogawa, Y | 1 |
| Kuwana, M | 1 |
| Mori, T | 1 |
| Watanabe, R | 1 |
| Nakajima, T | 1 |
| Yamada, M | 1 |
| Mashima, Y | 1 |
| Tsubota, K | 1 |
| Oguchi, Y | 1 |
| Giles, FJ | 1 |
| Kantarjian, H | 1 |
| O'Brien, S | 1 |
| Rios, MB | 1 |
| Cortes, J | 1 |
| Beran, M | 1 |
| Koller, C | 1 |
| Keating, M | 1 |
| Talpaz, M | 1 |
| Hambach, L | 1 |
| Eder, M | 1 |
| Dammann, E | 1 |
| Battmer, K | 1 |
| Stucki, A | 1 |
| Heil, G | 1 |
| Ganser, A | 1 |
| Hertenstein, B | 1 |
| Yamaguchi, H | 1 |
| Inokuchi, K | 1 |
| Yokomizo, E | 1 |
| Miyata, J | 1 |
| Watanabe, A | 1 |
| Inami, M | 1 |
| Tajika, K | 1 |
| Dan, K | 1 |
| Chou, T | 1 |
| Wakabayashi, M | 1 |
| Hayashi, N | 1 |
| Arakawa, M | 1 |
| Kawakubo, K | 1 |
| Ohyashiki, JH | 1 |
| Ohyashiki, K | 1 |
| Tauchi, T | 1 |
| Ohto, T | 1 |
| Toyama, K | 1 |
| Barbara, JA | 1 |
| Thomas, AC | 1 |
| Smith, PS | 1 |
| Gillis, D | 1 |
| Ho, JO | 1 |
| Woodroffe, AJ | 1 |
| Kobayashi, R | 1 |
| Naito, H | 1 |
| Shikano, T | 1 |
| Ishikawa, Y | 1 |
| Matsumoto, T | 1 |
| Tonooka, T | 1 |
| Sunder-Plassmann, G | 1 |
| Speiser, W | 1 |
| Korninger, C | 1 |
| Stain, M | 1 |
| Bettelheim, P | 1 |
| Pabinger-Fasching, I | 1 |
| Lechner, K | 1 |
| Collin, R | 1 |
| Griffiths, H | 1 |
| Polacarz, SV | 1 |
| Lawrence, AC | 1 |
| Watmore, A | 1 |
| Yoshizaki, N | 1 |
| Kohda, K | 1 |
| Nakazawa, O | 1 |
| Ando, M | 1 |
| Miyazaki, S | 1 |
| Muramatsu, H | 1 |
| Terada, S | 1 |
| Kure, T | 1 |
| Niitsu, Y | 1 |
| Kitajima, K | 2 |
| Nakada, H | 2 |
| Sakamaki, H | 1 |
| Nakamura, S | 1 |
| Maruyama, Y | 1 |
| Nagata, K | 1 |
| Yahara, Y | 1 |
| Onozawa, Y | 1 |
| Adachi, T | 1 |
| Takahashi, I | 1 |
| Osada, K | 1 |
| Fukuda, S | 1 |
| Ohmoto, E | 1 |
| Aoyama, S | 1 |
| Yorimitsu, S | 1 |
| Sanada, H | 1 |
| Nakadate, H | 1 |
| Hatayama, Y | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Investigator Initiated Open Study to Evaluate the Efficacy and Safety of Intra Arterial Infusion for Treatment of Steroid Resistant Acute Hepatic Graft Versus Host Disease (AGVHD)[NCT01140984] | 2 participants (Actual) | Interventional | 2010-09-30 | Terminated (stopped due to technical issues) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisolone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Examination; Chemorad | 2014 |
Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review.
Topics: Administration, Oral; Administration, Topical; Adult; Benzamides; Clobetasol; Drug Administration Sc | 2008 |
[Clinical progress in chronic myelogenous leukemia].
Topics: Benzamides; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dasatinib; Drug Discover | 2009 |
Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cycloph | 2006 |
Diffuse proliferative glomerulonephritis after bone marrow transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Glomerulonephritis, Membranoproli | 2002 |
Sweet's syndrome without granulocytosis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Biopsy; Diagnosis, Differential; Drug Eruptions; Female | 1998 |
[Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Female; Humans; Injections, | 1999 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation | 2001 |
Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Daunor | 2002 |
[A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
Topics: Aged; Aged, 80 and over; Busulfan; Drug Therapy, Combination; Female; Glomerulonephritis, Membranopr | 1989 |
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leuke | 1989 |
3 trials available for prednisolone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclopho | 1994 |
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort | 2001 |
[Treatment of chronic myelogenous leukemia (CML)--VP(M) regimen starting during its chronic phase, and the second nation-wide survey on the long-term survivors of CML in Japan].
Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Female; Humans | 1989 |
42 other studies available for prednisolone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
A case report of nilotinib-induced irreversible interstitial lung disease.
Topics: Adrenal Cortex Hormones; Biopsy; Cough; Humans; Idiopathic Interstitial Pneumonias; Leukemia, Myelog | 2022 |
Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.
Topics: Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pleural Effu | 2023 |
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia.
Topics: Adrenal Cortex Hormones; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, | 2023 |
Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogen | 2021 |
Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Dasatinib; Demyelinating Diseases; Drug Substitution; Female; | 2018 |
Myasthenia gravis unmasked by imatinib.
Topics: Adult; Blepharoptosis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; | 2019 |
Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report.
Topics: Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mo | 2018 |
Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, B | 2019 |
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; | 2019 |
Nilotinib-induced interstitial lung disease.
Topics: Aged; Benzamides; Diagnosis, Differential; Drug Substitution; Female; Glucocorticoids; Humans; Imati | 2013 |
Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.
Topics: Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Immunosuppressive Agents | 2014 |
Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
Topics: Acute-Phase Reaction; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag | 2016 |
Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia.
Topics: Adult; Benzamides; Drug Resistance; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-A | 2009 |
The 51st annual meeting of the American Society of Hematology.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Combined Modal | 2003 |
DEFICIENCY OF THE HYDRAZINE SENSITIVE COMPONENT OF COMPLEMENT IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA.
Topics: Animals; Blood Protein Electrophoresis; Busulfan; Complement System Proteins; Erythrocytes; Guinea P | 1963 |
[COMBINED TREATMENT OF CHRONIC MYELOCYTIC LEUKEMIA].
Topics: Blood Transfusion; Busulfan; Cortisone; Erythrocyte Count; Hemoglobinometry; Humans; Leukemia; Leuke | 1963 |
SKIN LESIONS IN CHRONIC MYELOID LEUKAEMIA.
Topics: Blood Transfusion; Busulfan; Dermatology; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL | 1964 |
Conduction block of varicella zoster virus neuropathy.
Topics: Action Potentials; Acyclovir; Antiviral Agents; Electrodiagnosis; Electromyography; Female; Glucocor | 2003 |
Interstitial pneumonitis during imatinib therapy.
Topics: Aged; Antineoplastic Agents; Benzamides; Female; Glucocorticoids; Humans; Imatinib Mesylate; Leukemi | 2004 |
Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, My | 2004 |
Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.
Topics: Antineoplastic Agents; Benzamides; Biopsy; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors | 2005 |
Imatinib-induced immune hepatitis: case report and literature review.
Topics: Adolescent; Alanine Transaminase; Antibodies, Antinuclear; Antibody Specificity; Antineoplastic Agen | 2007 |
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
Topics: Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous | 2007 |
Myasthenia gravis after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Ant | 1994 |
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co | 1993 |
[Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Leukemia, Mye | 1993 |
[Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Daunorubic | 1995 |
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Topics: Anemia, Hemolytic, Autoimmune; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 1995 |
Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Humans; Karyoty | 1996 |
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft | 1997 |
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host | 1998 |
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Dry Eye Syndromes; Female; Glucocorticoids; Graft | 2001 |
[Treatment of leukemia: discussion].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined | 1992 |
[Treatment of CML with blastic crisis by the combination therapy of VP and low-dose Ara-C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Humans; Leukemia, M | 1992 |
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marro | 1992 |
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antib | 1992 |
[Nonoliguric acute renal failure complicated with tumor lysis syndrome in chronic myelocytic leukemia in lymphoid crisis].
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Blood | 1991 |
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.
Topics: Adult; Aged; Antithrombin III; Blast Crisis; Disseminated Intravascular Coagulation; Female; Fibrin | 1991 |
Mithramycin therapy for resistant hypercalcaemia in transformed chronic granulocytic leukaemia.
Topics: Adult; Blast Crisis; Female; Fluid Therapy; Humans; Hypercalcemia; Leukemia, Myelogenous, Chronic, B | 1989 |
[Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; | 1989 |
[BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 1988 |